Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.
Download a publication order form here or subscribe here.
Talcum Powder Litigation Report - Issue: 31
Fla. Federal Court Refuses to Stay Proceedings in Talcum Powder Ovarian Cancer Action
Louisiana Court Remands Talcum Powder Claims, Says Connection with Imerys’ Bankruptcy Not ‘Sufficiently Strong’
Plaintiff Whose $55 Million Talcum Powder Verdict was Tossed Re-Files Complaint in MDL
J&J Defendants Continue Efforts to Fix Venue for All Talc Claims in Del. Bankruptcy Court
Talc MDL Plaintiffs Oppose ‘Broad’ Efforts by J&J to Toss Testimony from General Causation Experts
J&J Defendants File Brief in Talcum Powder MDL Supporting Testimony of Molecular Biologists
J&J Files Brief, Requests Oral Argument in Appeal of $110 Million Talc Ovarian Cancer Verdict
N.Y. Jury Adds $300 Million in Punitive Damages to Earlier $25 Million Award in Asbestos Cosmetic Talc Trial Against J&J
